These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
577 related articles for article (PubMed ID: 17496166)
1. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist. Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166 [TBL] [Abstract][Full Text] [Related]
2. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. Chapman RW; Minnicozzi M; Celly CS; Phillips JE; Kung TT; Hipkin RW; Fan X; Rindgen D; Deno G; Bond R; Gonsiorek W; Billah MM; Fine JS; Hey JA J Pharmacol Exp Ther; 2007 Aug; 322(2):486-93. PubMed ID: 17496165 [TBL] [Abstract][Full Text] [Related]
3. Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist. Dwyer MP; Yu Y; Chao J; Aki C; Chao J; Biju P; Girijavallabhan V; Rindgen D; Bond R; Mayer-Ezel R; Jakway J; Hipkin RW; Fossetta J; Gonsiorek W; Bian H; Fan X; Terminelli C; Fine J; Lundell D; Merritt JR; Rokosz LL; Kaiser B; Li G; Wang W; Stauffer T; Ozgur L; Baldwin J; Taveras AG J Med Chem; 2006 Dec; 49(26):7603-6. PubMed ID: 17181143 [TBL] [Abstract][Full Text] [Related]
4. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. Kaur M; Singh D J Pharmacol Exp Ther; 2013 Oct; 347(1):173-80. PubMed ID: 23912333 [TBL] [Abstract][Full Text] [Related]
6. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6. Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666 [TBL] [Abstract][Full Text] [Related]
7. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2. de Kruijf P; Lim HD; Overbeek SA; Zaman GJ; Kraneveld AD; Folkerts G; Leurs R; Smit MJ Eur J Pharmacol; 2010 Sep; 643(1):29-33. PubMed ID: 20599927 [TBL] [Abstract][Full Text] [Related]
8. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2. Aul R; Patel S; Summerhill S; Kilty I; Plumb J; Singh D Int Immunopharmacol; 2012 Jul; 13(3):225-31. PubMed ID: 22561413 [TBL] [Abstract][Full Text] [Related]
14. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat. Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761 [TBL] [Abstract][Full Text] [Related]
18. Il-8((3-73))K11R is a high affinity agonist of the neutrophil CXCR1 and CXCR2. Li F; Gordon JR Biochem Biophys Res Commun; 2001 Aug; 286(3):595-600. PubMed ID: 11511101 [TBL] [Abstract][Full Text] [Related]
19. Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonists. Biju P; Taveras AG; Dwyer MP; Yu Y; Chao J; Hipkin RW; Fan X; Rindgen D; Fine J; Lundell D Bioorg Med Chem Lett; 2009 Mar; 19(5):1431-3. PubMed ID: 19196511 [TBL] [Abstract][Full Text] [Related]
20. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]